Niemann-Pick disease, type C1 (NPC1) is a rare lysosomal lipidosis that is most often the result of biallelic mutations in NPC1, and is characterized by a fatal neurological degeneration. The pathophysiology is complex, and the natural history of the disease is poorly understood. Recent findings from patients with NPC1 and hearing loss suggest that multiple steps along the auditory pathway are affected. The current study was undertaken to determine the auditory phenotype in the Npc1 nih mutant mouse model, to extend analyses to histologic evaluation of the inner ear, and to compare our findings to those reported from human patients. Auditory testing revealed a progressive high-frequency hearing loss in Npc1 −/− mice that is present as early as postnatal day 20 (P20), well before the onset of overt neurological symptoms, with evidence of abnormalities involving the cochlea, auditory nerve, and brainstem auditory centers. Distortion product otoacoustic emission amplitude and auditory brainstem response latency data provided evidence for a disruption in maturational development of the auditory system in Npc1 −/− mice. Anatomical study demonstrated accumulation of lysosomes in neurons, hair cells, and supporting cells of the inner ear in P30 Npc1 −/− mice, as well as increased numbers of inclusion bodies, myelin figures, and swollen nerve endings in older (P50-P70) mutant animals. These findings add unique perspective to the pathophysiology of NPC disease and suggest that hearing loss is an early and sensitive marker of disease progression.
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INTRODUCTION
Niemann-Pick disease, type C1 (NPC1) is a rare (1:120,000-150,000) autosomal recessive disorder of lipid metabolism that typically affects children and is characterized by hepatic dysfunction in the neonatal/ infantile period and subsequent neurological decline.
It is a clinically and genetically complex and heterogeneous disease that most often results from biallelic mutations in NPC1. The principal metabolic defect alters cholesterol trafficking from lysosomes (Liscum and Faust 1987; Liscum et al. 1989) and creates an excess accumulation of unesterified cholesterol and other lipid moieties within cells and tissues throughout the body. There is preferential damage to neurons (Ordonez et al. 2012 ) and areas with high concentrations of lipids in the brain, such as myelin and neural plasma membranes (Vincent et al. 2003) . Onset of neurological symptoms classically begins in the late-infantile and juvenile years; however, age of presentation can range from the perinatal period to adulthood. The persistent and widespread neurodegeneration is fatal in all cases and, currently, there is no definitively effective intervention.
Early evidence suggested the auditory system is affected by NPC1 (Fink et al. 1989; Pikus 1991; Garver et al. 2007) , although it has likely been an underreported manifestation given the difficulty in obtaining behavioral audiological assessments from a pediatric, neurologically compromised population. Current data, including behavioral measures, auditory brainstem responses and distortion product otoacoustic emissions, obtained from a large cohort of humans with NPC1 (King et al. 2014 ) confirm a functionally significant, often high-frequency, progressive auditory phenotype with evidence for dysfunction in the peripheral and central auditory pathways.
Homozygous mutant Npc1 nih mice on a Balb/c background strain (Loftus et al. 1997 ) lack functional NPC1 protein and present with comparable molecular, anatomical, and biochemical phenotypes to humans with Niemann-Pick C disease. Affected animals show age-related Purkinje cell loss, demyelination in the corpus callosum (German et al. 2001; Weintraub et al. 1992) , widespread cortical effects (Ong et al. 2001) , and evidence for a global reduction in white matter tracts (Ory 2000) . Overt neurological symptoms (e.g., visible ataxia) may not manifest until postnatal day 45 (P45) or later, although retarded growth and neuromuscular dysfunction are present at 5 weeks (Võikar et al. 2002; Li et al. 2005) .
Therapeutic trials with 2-hydroxypropyl-ß-cyclodextrin (HP-ß-CD) have been conducted in feline and mouse models of NPC disease, and are currently being extended to humans with this genetic disorder. While HP-ß-CD has shown promising results in animal models by increasing the lifespan and ameliorating cerebellar neurodegeneration, profound and irreversible hearing loss has been observed in diseased and control cats treated with the drug (Ward et al. 2010 ). This presents a need to expand understanding of the auditory phenotype of NPC1 across species. Auditory function beyond the acoustic startle has not been reported in the Npc1 nih mouse; however, brainstem histology identified changes in central auditory system nuclei in mutant mice, including lower neural density in the ventral cochlear nucleus and a proliferation of astrocytes in the inferior colliculus and medial geniculate nuclei (Luan et al. 2008 ).
We present the first physiologic, electrophysiologic, and histologic longitudinal data from the cochlea and auditory nerve of the Npc1 nih mouse, which provide a unique perspective on the pathological processes associated with NPC1 mutations, and support the auditory system in this species as a useful marker for disease status, progression, and potentially therapeutic efficacy.
METHODS

Animals
Maintenance and care of the mice followed the +/− male and female mice (BALB/cNctr-Npc1 m1N /J strain). Genomic DNA was prepared from tail clip or ear punch biopsies, and genotypes were determined by PCR using forward primer (GGTGCTGGACAGCCAAGTA) and reverse primer (GATGGTCTGTTCTCCCATG) as described (Loftus et al. 1997) .
For auditory testing, 20 mice from each experimental (genotype) group were evaluated starting at P20 every 5 days until P65, for a total of 60 mice with 10 longitudinal data points. Given the neurodegenerative phenotype, endpoint criteria for euthanasia were established (15 % loss of total body weight or an observation that the animal was moribund, cachectic, or unable to obtain food or water). All animals survived until P65, although very few survived long after, thus establishing the experimental lifespan. For histologic evaluation, both ears from five to ten animals of each genotype were prepared at P30, P50, and P70.
Auditory Testing
Animals were anesthetized using a combined cocktail of ketamine and dexdormitor (56 mg/kg bodyweight and 0.375 mg/kg bodyweight, respectively), administered via subcutaneous injection. Total dosage of anesthesia was weight dependent, and neither of these drugs is known to affect auditory function in this species. Animals were placed on a heating pad, and their temperature was maintained at 37°C via a rectal thermometer throughout testing in a sound-shielded test booth. The examiner was blind to the genotype, although in older mice, mutants could be identified based on an overt neurological phenotype.
Distortion product otoacoustic emissions (DPOAE) were recorded with an ER-10C (Etymotic Research, Inc., Elk Grove Village, IL) speaker-probe assembly using the DP2000 DPOAE measurement system, version 3.0 (Starkey Laboratories, Eden Prairie, MN). The speaker-probe assembly was placed in the external auditory canal of the animal. Two tones (f 1 and f 2 , f 2 9f 1 ) were presented at f 1 =65 dB SPL and f 2 =55 dB SPL. Calibration of the two tones took place in situ. The tones were varied in one twelfth octave steps from f 2 = 5,297 to 10,641 Hz, based on the frequency limitations of the speaker-probe assembly, with a constant frequency ratio (f 2 /f 1 ) of 1.2. DPOAE amplitudes were recorded from both ears of each animal and then the amplitudes were averaged, along with the noise floors.
Following DPOAE collection, ABRs were obtained from a single ear (counterbalanced between animals, and maintained throughout longitudinal testing). Three subdermal needle electrodes (forehead and both mastoids) were placed for recording. ABR stimuli were generated with the auditory-evoked Intelligent Hearing Systems (Miami, FL) software and produced through a high-frequency (HFT9911-20-0035), closed-field transducer. ABR thresholds were obtained using a negative polarity (rarefaction) click stimulus, as well as 8, 16, and 32 kHz tone pips, presented at a rate of 21/s. Duration of the stimulus was 47 and 1,000 μs for click and tone-pip stimuli, respectively. Prior to beginning threshold searches, a response to a high intensity (e.g., 110 dB SPL) suprathreshold stimulus was collected and used to determine absolute and interpeak latencies, as well as waveform amplitude. The same number of artifactfree sweeps (1,024) was collected to obtain the suprathreshold response at every test session on each animal.
ABR threshold search began with a 110-dB SPL signal for click, 8 and 16 kHz stimuli, and a 100-dB SPL signal for the 32 kHz stimulus (based on equipment limitations). The intensity was then decreased in 10 dB steps until no response was obtained, followed by 5 dB steps at lower intensities near threshold. Threshold was defined as the lowest intensity level (dB SPL) that elicited a time-locked and replicable response waveform above the noise floor. The noise floor was evaluated via a control run using a 0-dB SPL stimulus. A minimum of 400 artifact-free sweeps were obtained for each waveform. Following collection of suprathreshold data and determination of thresholds for click and tonepip stimuli, the effects of sedation were reversed using an antecedent, and the animal was returned to a recovery cage.
Histology
Light and Transmission Electron Microscopy
Mice were killed under deep anesthesia (ketamine/ xylazine/acepromazine), and both temporal bones were quickly removed from the skull. Middle and inner ears were opened bilaterally and perfused with, then fixed in, 2.5 % glutaraldehyde in 0.1 M sodium phosphate buffer (PBS; pH 7.4; Sigma Aldridge, St. Louis) for 5-7 days at 4°C. Tissues were then rinsed in PBS. Several embedding methods were used to screen for pathological changes in the tissue. Tissues used for screening of the entire inner ear were embedded in JB-4 (Electron Microscopy Sciences, Hatfield PA). The embedding process was as follows: fixed tissue was decalcified in 0.35 M EDTA at room temperature for at least 7 days with constant agitation. Tissues were then rinsed in PBS, dehydrated in a series of ethanol solutions of increasing concentration, and embedded in JB-4. For closer examination at the ultramicroscopic level, glutaraldehyde-fixed tissue was stained in 1 % osmium tetroxide in PBS, rinsed in PBS and decalcified, rinsed in PBS, dehydrated in a series of ethanol solutions, and embedded in Embed-812 (Electron Microscopy Sciences, Hatfield PA). Tissues embedded in either compound were serially sectioned at a thickness of 4-5 μm, mounting every third section. The sectioning was performed in a plane approximately parallel to the long axis of the modiolus. Sections were stained with toluidine blue, coverslipped, and examined under an Olympus BH2 compound microscope (Olympus, Center Valley, PA). For transmission electron microscopy, ultrathin sections were taken in the same orientation as the light microscopy sections. Sections were stained with lead citrate and uranyl acetate and examined using a JEOL 1200EX transmission electron microscope made available by the UT Southwestern Electron Microscopy Core.
Post hoc quantification of elongation of the major axis of the spiral ganglion cell soma was performed on sections from JB-4 embedded P30 ears, using images from ears of three NPC and three control mice. Analysis included only mid-modiolar sections in which the organ of Corti was cross-sectioned and the majority of the nerves within Rosenthal's canal were longitudinally sectioned. The area of analysis was restricted to spiral ganglion in the region ½ to ¾ turn apical from the round window membrane. Images were taken from 3-4 sections of each ear, with the sections spaced approximately 30 μm apart. Images were randomized, and randomly placed line-grids were projected across each photo. Only cell somata that touched the line intersections were counted. The ratio of the lengths of the major versus minor axes of the cells was obtained for cells in which the nucleus and nucleoli were present. Two examiners blinded to the condition of each image measured a total of 169 cells from NPC mice and 203 cells from control mice utilizing Image J software. Statistical analysis was performed on the population of cells from NPC and control mice utilizing Student's t test.
Filipin Staining
Mice were placed under deep anesthesia (ketamine/ xylazine) and subjected to transcardial perfusion with 4 % formalin. Both temporal bones were quickly removed, the middle and inner ears opened and immersed in formalin for 7 days, then rinsed in PBS. The inner ear was dissected in PBS, without decalcification, and incubated with filipin (final concentration of 50 μg/ml in PBS; Sigma, F-9765) for 1.5 h with gentle rotation and shielding from light. The tissue pieces were washed 3 times with PBS, then mounted on glass slides and imaged using a DVRT Deltavision Deconvolution Microscope (inverted wide-field epifluorescence microscope) made available by the UT Southwestern Live Cell Imaging Core. Filipin signal was acquired using the following UV settings: excitation, BP 360/40; emission, BP 470/40; and dichroic mirror, 400, as kindly recommended by Fred Maxfield (Weill Cornell Medical College). Exposure times were the same for wild type and NPC1 −/− samples (0.5 s). For each specimen, Z-stacks of 60 images were acquired with a step size of 0.15 μm. Z-stacks were deconvolved using Autoquant software (Media Cybernetics). Images in Figure 6 are maximum-intensity projections of the deconvolved Z-stacks using the Image 9Stacks 9Z Project function in ImageJ.
Statistical Analysis
Data were maintained and analyzed using Microsoft Excel, the Statistical Package for Social Sciences Software (SPSS, v15) and the SAS (SAS, v9.1) software packages. For all statistical analyses, α=0.05.
To evaluate neural and cochlear function, change over time, and effect of disease within gender, DPOAE (averaged between the right and left ears) and ABR data were analyzed with the Proc MIXED procedure in SAS 9.1 using a repeated measures model with autoregressive correlation matrix structure (Crowder and Hand 1990) instead of the more commonly used compound symmetry model. The autoregressive structure postulates that the correlation is stronger between time points that are closer together and weaker between time points that are farther apart. Fit statistics confirmed the logical assumption that the autoregressive model was more appropriate for this dataset.
DPOAE amplitude and ABR (click and tone pip) threshold, suprathreshold peak latency (absolute and interpeak) and suprathreshold peak amplitude were evaluated in separate analyses. For all dependent variables, the assumed model was:
Preliminary analyses revealed no significant differences in measures of hearing (DPOAE amplitude, ABR threshold, latency, and amplitude) between Npc1 nih heterozygous carriers (+/−) and control (+/+) littermates. Therefore, data from these two groups were pooled to establish a larger control data set (Npc1 nih +/−, +/+) and increase statistical power.
RESULTS
Npc1 nih Mutant Mice Exhibit Hearing Loss as Early as Postnatal Day 20 that Deteriorates Across the Lifespan
Repeated measures modeling revealed that homozygous mutant Npc1 nih mice have significantly (pG0.05) elevated ABR thresholds at P20 compared with heterozygous (Npc1 nih +/−) and control (Npc1 nih +/+) animals at 16 and 32 kHz (Fig. 1A) and by P65 this pattern is present for all test stimuli (Fig. 1B) . Data from our control animals (BALB/c-Npc1 nih +/−, +/+) indicate that age-related decline in high-frequency hearing (32 kHz, Fig. 2D ) can begin earlier than previously reported in this background strain (Willott et al. 1998) .
Npc1 nih homozygous mutant mice exhibited significant progressive elevations in ABR thresholds at rates of 0.32, 0.4, and 0.7 dB every 5 days for click, 8 and 16 kHz stimuli, respectively, with no significant change in the hearing of control animals ( Fig. 2A-C) . Repeated measures modeling identified a significantly (pG0.02) poorer ABR threshold in Npc1 nih homozygous mutant mice compared with controls for click and 8 kHz stimuli by P35. At 32 kHz, control animals exhibited a significant elevation in ABR threshold of 3.6 dB every five days, while thresholds of Npc1 nih homozygous mutant animals remained stable (Fig. 2D) . Despite the progressive elevation in 32 kHz thresholds for control animals, Npc1 nih homozygous mutant mice had significantly poorer ABR thresholds at 32 kHz across the entire experimental lifespan.
Otoacoustic Emissions Support a Functional Cochlear Lesion and Suggest Disruption in Sensory Maturation in the Npc1 nih (−/−) Mouse
To localize a functional site of lesion for the elevated ABR thresholds observed in Npc1 nih homozygous mutant mice, 2f 1 -f 2 DPOAE amplitudes were analyzed longitudinally in Npc1 nih mutant and control (+/−, +/+) animals from 5,297 to 10,641 Hz. DPOAEs are believed to reflect active biological processes within the cochlea, specifically electromotile properties of the outer hair cells. Both Npc1 nih homozygous mutant mice and control animals displayed relatively robust signal-tonoise ratios (SNR) across the experimental lifespan (Fig. 3A versus B 
ABR Latencies Implicate Maturational Disruption of Neural Auditory Pathways in Npc1 nih (−/−) Mice
To evaluate the functional integrity of the auditory nerve and auditory brainstem tracts, ABRs were measured in response to high-intensity stimuli and absolute (I, II, III, IV, and V) and interpeak (I-III, III-V, and I-V) latency data from the component peaks of the waveform were analyzed. For the click stimulus (Table 2 , P20 Latency), there were no significant differences in absolute or interpeak latency at P20 between Npc1 nih homozygous mutant mice and control (+/−, +/+) animals. Latency data from mutant mice did not change significantly over time, with the exception of a slight increase (0.005 ms/5 days) in the absolute latency of wave I. Conversely, control animals exhibited a significant decrease in latency over time across all component peaks of the waveform. In general, the effect was greater for later-occurring waves (Table 2 ; Fig. 4) .
A similar pattern as the one observed with a click stimulus was seen for the tone-pip ABR stimuli (data not shown). Few differences in latency existed between control (+/−, +/+) and mutant (−/−) Npc1 nih animals at P20, and of those (n=6) all but one (wave II, 8 kHz) revealed that Npc1 nih mutant mice had prolonged latencies compared with control animals. The more robust finding, however, was that for all ABR stimuli, control animals underwent a significant decrease in latency across the experimental lifespan at almost every component of the waveform. As with the click stimulus, the effect was generally greater for later-occurring waves. Npc1 nih homozygous mutant mice, however, exhibited far fewer significant changes Differences between control and heterozygous groups are not statistically significant at any frequency. *pG0.05; **pG0.001.
in latency over this time period, and most changes involved a prolongation in the absolute latency of early waves, with a concomitant decrease in interpeak latencies. These progressive shifts across the experimental lifespan culminated in Npc1 nih homozygous mutant mice having significantly longer latencies than control animals for all but three (29/32) ABR waveform components at P65 (Table 2 for click stimuli; data not shown for tone-pip stimuli).
ABR amplitudes (data not shown) revealed no clear effect of disease for either the click or 8 kHz stimuli. Smaller amplitudes were noted for 16 and 32 kHz stimuli in homozygous mutant Npc1 nih mice compared with controls (+/−, +/+), primarily for the early ABR peaks (I, II, and III), which is consistent with the early-onset hearing loss observed at these frequencies.
Gender differences in auditory function were not significant in most analyses (data not shown).
Histological Changes Indicate Cholesterol Accumulation Occurs in Cochlear Tissue by P30
Imaging of plastic embedded toluidine blue-stained cochlear tissue revealed cellular changes in the cochlear duct of homozygous mutant Npc1 nih mice compared with controls (Npc1 +/+) that were apparent at the light microscopic level by P30. The changes most consistently seen at this time were accumulation of lysosomes or inclusion bodies in the spiral ganglion cells that appeared to cause expansion of the cell soma at both poles and accumulation of inclusion bodies within the supporting cells of the organ of Corti and stria vascularis. Determination of the ratio of the lengths of the major versus minor axes of the spiral ganglion cell soma revealed a significant difference in axis ratio for the population of 
Npc1
nih (−/−) cells was 1.81 (±0.44 (standard deviation), n=169) versus 1.66 (±0.38, n=203) for control. By P30, swelling could also be seen in the afferent and efferent fibers within the organ of Corti (Fig. 5) , which become more apparent by P50 and P70. Similar changes have been reported for CNS neurons in NPC disease (Walkley and Suzuki 2004) .
Filipin staining of cochlear tissue from P50 homozygous mutant Npc1 nih−/− mice revealed bright punctate staining within cells of the stria vascularis and the organ of Corti (Fig. 6) . Filipin, a fluorescent probe that forms a complex specifically with unesterified cholesterol, reveals the lysosomal sterol accumulation that is a hallmark of this disease (Patterson et al. 2001) . Lysosomal sterol/filipin was only observed in Npc1 nih−/− mice and was readily apparent in the intermediate cell layer of the stria vascularis and supporting cells of the organ of Corti, although some staining of vesicles was also seen in inner and outer hair cells. Punctate filipin staining was not detected in (Fig. 7) and correspond in location to the unesterfied cholesterol identified by filipin staining. However, the accumulations seen in the spiral ganglion appear to differ and, therefore, are unlikely to be unesterified cholesterol. Swollen nerve endings found in the organ of Corti appear to be filled with cellular debris.
DISCUSSION
We present data that, for the first time, identify hearing loss in a common mouse model for NPC1 disease. BALB/c-Npc1 nih homozygous mutant mice exhibited elevation in high-frequency ABR thresholds as early as P20, which is weeks before diseased mice show deficits in the acoustic startle (Maue et al. 2011) or overtly display neurologic impairment (e.g., ataxia, tremor, and dystonia). This finding was completely penetrant across mutant offspring within the first 3 weeks of life, which suggests early deterioration, maturational dysfunction, or both within the auditory system. Our histological observations revealed cellular changes in cochlear tissues and peripheral auditory nerve. Filipin staining demonstrated abnormal lysosomal cholesterol accumulation in cells of the organ of Corti and stria vascularis, which both contribute to Results of repeated measures modeling for ABR latency (ms) at P20 and P65 and ABR latency progression data (ms) for click stimuli The significantly smaller DPOAE amplitudes in Npc1 nih homozygous mutant mice compared with controls (+/−, +/+) indicate less robust cochlear outer hair cell function and support a cochlear contribution to the hearing loss at P20. The increase in DPOAE amplitude in Npc1 nih control (+/−, +/+) animals observed across the experimental lifespan suggests postnatal cochlear maturation through at least P65 in this BALB/c background strain. These changes in amplitude were larger for lower frequencies (G7 kHz) and similar to those observed in C57BL/6J mice (Narui et al 2009) . This suggests the basal region of the cochlea may be more developmentally mature in the BALB/c background strain, and that regions more apical undergo postnatal developmental changes in the mechanical properties of the basilar membrane or the electromotility of the outer hair cells (Long and Tubis 1988; Brown et al. 1989) or stereocilia bundle (Liberman et al. 2004 ). As differences in DPOAE development were observed between Npc1 nih homozygous mutant mice and controls (+/−, +/+), and as NPC1 has no known or predicted effects on middle ear physiology, it is reasonable to hypothesize that the observed effects on DPOAE amplitude in the current study are based on changing properties of the developing cochlea and that NPC1 pathogenesis may disrupt maturational processes or accelerate age-related changes in mice.
By P65, homozygous mutant Npc1 nih mice had significantly longer latencies for the component peaks of the ABR waveform compared with control (+/−, +/+) animals, which did not correlate with the neurodegenerative phenotype in the mutants, but, rather, reflected a significant shortening in latency for control animals. To the best of our knowledge, developmental changes in ABR latency in mice have not been reported previously, although similar changes have been well documented in other mammals, including humans (Hecox and Galambos 1974) . While initial detection and saturation of the ABR (threshold) has been reported in C57BL/6J mice (Lenoir and Puel 1987) , our data provide a more detailed depiction of postnatal maturation of the ABR in the BALB/c background strain. Almost every component peak of the ABR exhibited significant progressive shortening with age in control animals, and the effect was larger for later-occurring peaks. A similar maturational effect was observed for ABR amplitude, where all mice demonstrated a significant decrease in waveform amplitude across the experimental lifespan (data not shown). This postnatal change in ABR latency and amplitude did not occur in Npc1 nih homozygous mutant mice, thus providing further support for disease-related maturational disruption. We cannot rule out the additional possibility, however, that normal maturation in mutant animals is masked by concurrent degeneration within the auditory system. Auditory brainstem histopathology has been localized to the cochlear nucleus, inferior colliculus, and medial geniculate nucleus of Npc1 nih mutant animals (Luan et al. 2008) , which corresponds to our data that indicate dysfunctional neural activity in Npc1 nih mutant mice underlying the later component peaks of the ABR (e.g., wave V). Prolongation in later waves (e.g., wave V) and interpeak latencies (e.g., III-V) of the ABR cannot be explained by cochlear hearing loss alone and reflect delay in transmission time through the auditory brainstem.
The relationship between over-accumulation of cholesterol and hearing has been examined, but remains unclear. In humans, inconclusive evidence suggests a correlation between hyperlipidemia and sensorineural hearing loss (Evans et al. 2006; Preyer et al. 2001) , with speculation that the effect may be greater at the cochlear basal turn and corresponding high frequency test region where the cochlea is more susceptible to ischemic change (Cunningham and Goetzinger 1974) . Deleterious effects of hyperlipidemia on hearing and cochlear morphology have been shown in mice (Guo et al. 2005) and guinea pigs, which, collectively, support a complex role for cholesterol and other lipids in the auditory system. Systemic effects of hyperlipidemia, however, may affect the ear differently than localized accumulation of unesterfied cholesterol seen in NPC1.
Within the cochlea, cholesterol regulates lipid composition, mobility, and stiffness of the lateral walls of the outer hair cells (Evans et al. 2006) . Changes in cochlear cholesterol levels can modulate the amplitude of DPOAEs in mice, highlighting the intimate relationship between cholesterol in the outer hair cell wall and the membrane protein prestin that regulates nih mice in the current study did not achieve levels consistent with their control littermates during maturation. We speculate that disease-related alterations in the processing of cellular cholesterol prohibit the natural reduction in cholesterol necessary for cochlear cells to mature completely. As unesterified cholesterol, sphingolipids, and gangliosides accrue within cells throughout the disease process, further detrimental effects on cellular structure and function are likely, and may manifest as progressive declines in auditory function. This hypothesis applies to both cochlear cells, and areas of neural tissue with high concentrations of lipids, including the myelinated auditory nerve, accounting for both the cochlear and neural dysfunction we observed in Npc1 nih homozygous mutant animals. Furthermore, these data may reflect an association between Npc1 pathogenesis and an accelerated onset of age-related deterioration in the inner ear and neural auditory pathway. Additional histological studies, evaluation of serum cholesterol levels in the cochlea, and novel research exploring the role of cholesterol in the auditory system of the developing Npc1 nih mouse are necessary to explore these theories. Recent auditory data from humans with NPC1 (King et al. 2014 ) support the presence of auditory dysfunction in most patients with the disease. Despite a heterogeneous sample, functionally significant high frequency hearing loss was observed in over half of the cohort and the hearing loss was progressive in a subset of patients followed longitudinally. The presentation in the majority (66 %) of individuals was consistent with a neural site of lesion involving the auditory nerve and auditory brainstem pathways, although cochlear involvement was also evident. The findings herein are consistent with those reported in humans with NPC1, although not entirely parallel. Other mouse models of NPC1 (Npc1 nmf164 ) have a less severe neurological presentation than the Npc1 nih mouse (Maue et al. 2011) , and it will be useful to extend the examination of genotype-phenotype differences to auditory function in these models. Understanding how the auditory system is affected in both a heterogeneous human population and inbred homogenous animal models like the Npc1 nih mouse has important implications when considering markers for disease status, progression, and future therapeutic safety and efficacy.
